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S112 Chronic Kidney DiseaseSBP, DBP, BMI, WC, WHR, TG, TC, LDL, BUN, Scr, UA and FBG were seen in
CKD patients compared with the healthy control group, while the lower level
of hemoglobin, albumin and HDL were shown in the CKD group. (3) Multivar-
iate logistic regression model analysis showed WHR was positively correlated
with CKD (OR Z 9.470; 95% CI, 3.146e28.511; P < 0.001). (4) Compared to
the other indices of obesity, ROC curve analysis showed WHR was the best
diagnostic indicator in predicting CKD. The AUC of WHR, WC and BMI were
0.847 (95% CI, 0.804e0.890), 0.840 (95% CI, 0.799e0.882) and 0.755 (95%
CI, 0.703e0.807), respectively. A cut-off value of 0.87 of WHR had a sensi-
tivity of 76.6% and a specificity of 82.1%.
Conclusion: In the indices of obesity, WHR was an optimal predictor in pre-
dicting CKD. In addition, it is easy to use.http://dx.doi.org/10.1016/j.hkjn.2015.09.160
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Objective: The growing burden of end-stage renal disease (ESRD) has been a
great challenge to the health care system of China. However, the exact
epidemiological data for ESRD in China remain unclear. We aimed to deter-
mine the real burden of ESRD in China through analyzing ten-year data of
Nanjing three million insurance covered population.
Methods: Using the electronic registry system of Urban Employee Basic Med-
ical Insurance (UEBMI), we included all subjects insured by UEBMI in Nanjing
from 2005 to 2014, and we identified subjects who developed ESRD in this
cohort. The prevalence, incidence, mortality rate and long-term survival
rate of ESRD were analysed based on this unique data system.
Results: The UEBMI population in Nanjing increased from 1,301,882 in 2005
to 2,921,065 in 2014, among which a total of 5840 subjects developed ESRD
and received RRT. Over the 10-year period, the annual incidence rates of
ESRD in the UEBMI cohort in Nanjing gradually decreased from 289.3 pmp
in 2005 to 218.8 pmp in 2014. However, the prevalence rate increased
steadily from 891.7 pmp in 2005 to 1228.6 pmp in 2014. The annual mortality
rate decreased from 138.4 per 1000 patient-years in 2005 to 97.8 per 1000
patient-years in 2014. The long-term survival rate of ESRD fluctuated over
the past decade, with the 1-year survival rate ranging from 85.1% to
91.7%, the 3-year survival rate from 69.9% to 78.3% and the 5-year survival
rate from 58% to 65.4%.
Conclusion: China is confronted with enormous burden of ESRD and will
possess the largest population requiring RRT in the world with medical re-
form. Medical communities and the government should undertake active
measures to control this coming crisis.http://dx.doi.org/10.1016/j.hkjn.2015.09.161
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Objective: To evaluate the impact of improvement of cardiac function after
cardiac valve surgery to the renal outcome in preoperative renal dysfunction
patients.
Methods: Data from patients who had preexisting renal dysfunction [serum
creatinine (SCr)> 1.2 mg/dl, or eGFR 60 mL/min/1.73 m2) and received car-
diac valve surgery from April 2009 to May 2011 were analyzed.6LVEFZ postoperative LVEF e preoperative LVEF. Patients were grouped ac-
cording to thepostoperative cardiac function changeas following: Cardiac func-
tion not improved (CFNI group)Z 6EF  0%; Cardiac function improved (CFI
group) Z 6EF > 0%. Cardiac function significantly improved (CFSI
group) Z 6EF  15%. Cardiac function partial improved (CFPI
group)Z 0% <6EF < 15%.
Results: A total of 164 patients were enrolled. Pre- and postoperative LVEF
were 58  11% and 59  11%. Pre- and postoperative SCr were 1.7  0.8 and
1.6  1.1 mg/dl. The postoperative incidence of AKI was 44% (nZ 72), inci-
dence of AKI requiring replacement therapy (AKI-RRT) was 9% (nZ 14). The
AKI incidence in CFI group was significantly lower than in CFNI group (35% vs.
57%, PZ 0.009). There was no statistical significance of AKI eRRT incidence
and postoperative SCr between the two groups (5% vs. 13%, P Z 0.087;
1.5  0.8 vs. 1.8  1.5 mg/dL, P Z 0.135). The AKI incidence in CFSI group
and CFPI group were both significantly lower than in CFNI group (34% vs. 57%,
P < 0.05; 36% vs. 57%, P < 0.05). The postoperative SCr in CFSI group was
lower than preoperative SCr in the same group (1.2  0.3 vs.
1.4  0.2.mg/dL, P Z 0.027). Multivariate logistic regression analysis
showed that improved cardiac function after surgery (OR Z 0.42; 95% CI,
0.2e0.86) can reduce the risk of AKI while age (OR Z 1.06; 95% CI,
1.02e1.09) was independent risk factor of AKI.
Conclusion: For patients with preoperative renal dysfunction and cardiac
function improved after surgery, the AKI incidence would significantly lower
than those whose cardiac function not improved and postoperative renal
function is probably better than renal function before surgery.http://dx.doi.org/10.1016/j.hkjn.2015.09.162
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Objective: Sagliker Syndrome (SS), with craniofacial deformation, is a rare
disease derived from uremic secondary hyperparathyroidism (SHPT). This
study aims to investigate the clinical features of SS in Chinese patients.
Methods: We retrospectively assessed 9 SS patients underwent total para-
thyroidectomy (TPTX) with autotransplantation (AT). The other 137 common
SHPT patients with the same treatment were observed as the control group.
Clinical presentations, laboratory tests and follow-up data were recorded.
The follow-up status was considered as “effectiveness” if serum intact para-
thyroid hormone (iPTH) levels were <150 pg/mL in the first 3 days after sur-
gery, or as “recurrence” if serum iPTH gradually increased >300 pg/mL
during follow-up in patients whose status was initially considered as
“effectiveness”.
Results: Craniofacial deformations (9/9 vs. 0/137, SS vs. control, the same
below), short stature (9/9 vs. 16/137), thoracocyllosis (9/9 vs. 38/137)
and spine malformations (9/9 vs. 29/137) were observed in SS patients
significantly more frequently than in the control group (P < 0.05). The level
of serum iPTH and alkaline phosphatase were significantly elevated in SS pa-
tients than in control. Mean iPTH levels reached up to 3242.5 pg/mL in SS
and 1786.3 pg/mL in control (P < 0.05). After surgery, one SS patient died
from respiratory failure, and no control group patient died. Surgery was
effective in the remaining 10 SS patients with stopped craniofacial deforma-
tion and in 134/137 control group patents (P > 0.05). A mean follow-up of
16.5 (6 to 24) months was available. 6/11 SS patients and 8/137 control
group patients suffered from recurrence of hyperparathyroidism originating
from autografts (P < 0.05).
Conclusion: Our data suggests that SS is not only craniofacial malformations
but is a severe systemic disease. TPTX with AT seems an effective treatment
to relieve SHPT and to improve bone disease. SS, as a severe disease with
high postoperative recurrence tendency, is sufficed to show a disaster in Chi-
nese SHPT patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.163
